U.S. markets closed
  • S&P Futures

    4,116.50
    -10.00 (-0.24%)
     
  • Dow Futures

    33,659.00
    -44.00 (-0.13%)
     
  • Nasdaq Futures

    13,726.00
    -68.25 (-0.49%)
     
  • Russell 2000 Futures

    2,179.90
    -4.10 (-0.19%)
     
  • Crude Oil

    62.61
    +0.17 (+0.27%)
     
  • Gold

    1,781.90
    +3.50 (+0.20%)
     
  • Silver

    25.90
    +0.06 (+0.23%)
     
  • EUR/USD

    1.2037
    -0.0004 (-0.04%)
     
  • 10-Yr Bond

    1.5620
    -0.0390 (-2.44%)
     
  • Vix

    18.68
    +1.39 (+8.04%)
     
  • GBP/USD

    1.3934
    -0.0003 (-0.02%)
     
  • USD/JPY

    107.9760
    -0.0940 (-0.09%)
     
  • BTC-USD

    55,994.77
    +961.18 (+1.75%)
     
  • CMC Crypto 200

    1,282.73
    +48.32 (+3.91%)
     
  • FTSE 100

    6,859.87
    -140.21 (-2.00%)
     
  • Nikkei 225

    28,447.54
    -652.84 (-2.24%)
     

BioTelemetry, Inc. to Release Second Quarter 2020 Earnings Results on July 30, 2020

  • Oops!
    Something went wrong.
    Please try again later.
BioTelemetry, Inc.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

MALVERN, Pa., July 23, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2020 earnings on Thursday, July 30 at 4:00 PM Eastern Time.

The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Thursday, July 30, 2020. The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com. If you are unable to participate during the live webcast, an archive will be available on the website for two weeks.

About BioTelemetry
BioTelemetry, Inc. is the leading remote medical technology company focused on delivery of health information to improve quality of life and reduce cost of care. We provide remote cardiac monitoring, centralized core laboratory services for clinical trials, remote blood glucose monitoring and original equipment manufacturing that serves both healthcare and clinical research customers. More information can be found at www.gobio.com.

Contact:
BioTelemetry, Inc.
Heather C. Getz
Investor Relations
Executive Vice President, Chief Financial Officer
800-908-7103
InvestorRelations@biotelinc.com